JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knapp, J.
Right arrow Articles by Neumann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knapp, J.
Right arrow Articles by Neumann, J.

Vol. 294, Issue 2, 620-626, August 2000


Cantharidin Enhances Norepinephrine-Induced Vasoconstriction in an Endothelium-Dependent Fashion1

Jörg Knapp, Peter Bokník, Bettina Linck, Hartmut Lüss, Frank U. Müller, Lars Petertönjes, Wilhelm Schmitz and Joachim Neumann

Institut für Pharmakologie und Toxikologie, Universität Münster, Münster, Germany


    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In this study we characterized the effects of the protein phosphatase (PP) type 1 and type 2A inhibitor cantharidin (Cant) and its structural analogs cantharidic acid and endothall on PP activity, force of contraction, and myosin light chain phosphorylation in rat aorta. All compounds inhibited PP activity in homogenates of rat aorta with a rank order of potency of Cant = cantharidic acid > endothall. However, only Cant increased force of contraction and myosin light chain phosphorylation in intact isolated rat aortic rings. Based on these findings, we investigated the effects of Cant on alpha -adrenoceptor-mediated vasoconstriction. Cant (1 and 3 µM) enhanced norepinephrine-induced contraction in endothelium-intact rat aorta. In contrast, Cant did not affect norepinephrine-induced contraction in endothelium-denuded rat aorta. We suggest that inhibition of PP1 and/or PP2A activities by Cant enhances vascular contractility in endothelium-intact rat aorta by increasing the phosphorylation state of endothelial regulatory proteins.


    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Phosphorylation is an important post-translational modification of proteins. For instance, the phosphorylation of myosin light chain (MLC20) initiates smooth muscle contraction. Myosin light chain kinase increases and myosin light chain phosphatase(s) decrease(s) phosphorylation of MLC20. The main myosin light chain protein phosphatases (PPs) are PP1 and PP2A, which are comprised of catalytic and one or more regulatory subunits. Different genes encode the catalytic subunits PP1alpha , 1beta , 1gamma , 2Aalpha , and 2Abeta (for review, see Shenolikar and Nairn, 1991; Wera and Hemmings, 1995; Herzig and Neumann, 2000).

One can distinguish between PP1 and PP2A by their sensitivity toward PP inhibitors. PP2A is more sensitive to okadaic acid (OA) and cantharidin (Cant) than PP1. Cant is a less potent inhibitor of PPs than OA but more economical. Other PP inhibitors such as calyculin A are equipotent for PP1 and PP2A. However, additional structural derivatives of Cant inhibit purified PPs. These compounds include cantharidic acid (CA) and endothall (ETA; Erdödi et al., 1995; Laidley et al., 1996). They might be useful for correlation of PP inhibition and physiological function. CA was even claimed to be the active derivative of Cant (Eldridge and Casida, 1995).

We used these tools to study the hypothetical interaction between PP inhibition and contractile effects of catecholamines. For instance, Cant attenuated the relaxant effect of beta -adrenoceptor stimulation in bovine coronary arteries, probably by increasing phosphorylation of MLC20 via inhibition of PP (Knapp et al., 1997). Therefore, we hypothesized that PP inhibition may enhance or attenuate the vasoconstrictory effect of norepinephrine (NE). However, NE did not induce any vasoconstriction but, in contrast, led to vasorelaxation in bovine coronary arteries (Knapp et al., 1997). Because NE induces vasoconstriction of rat aorta (Alosachie and Godfraind, 1988), herein we used isolated rat aorta instead of bovine coronary artery. We first studied whether PP1 and PP2A are enzymatically present in rat aorta and investigated the effects of Cant, CA, and ETA on PP activity. For comparison, we used the well characterized compound OA. Thereafter, we tried to identify the catalytic subunits of PPs with antibodies.

The next question was whether the inhibitors could actually increase the contraction in aortic preparations and finally whether increased phosphorylation of MLC20 accompanies these contractions. Based on the results of these experiments, we studied the functional interaction of PP inhibition and NE-induced contraction of rat aorta.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Rat Isolated Aortic Ring Preparation

Male Wistar rats (300-350 g) were sacrificed by cervical dislocation. The thoracic aorta (aorta thoracica descendens) was dissected and transferred into Krebs-Henseleit solution (KHS) of the following composition: 118 mM NaCl, 25 mM NaHCO3, 2.5 mM CaCl2, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 11.1 mM glucose, and 0.026 mM ethylenedinitrilotetraacetic acid continuously gassed with 95% O2 and 5% CO2. Rat aortae were cleaned from connective tissue and cut into four rings of an approximate length of 4 mm. In indicated experiments, the endothelium was removed by gentle application of 100 µl of Triton X-100 (1%) followed by several rinses in KHS. Rings were individually mounted in organ chambers containing KHS and were allowed to equilibrate in KHS for 60 min under a resting tension of approximately 15 mN (Seasholtz et al., 1997). After equilibration rings were contracted twice with KCl (75 mM; 25 min) without correction of NaCl in the KHS. After washout, the presence of an undamaged endothelium was checked by relaxation to carbachol (CB; 1 µM; 10 min) after precontraction with NE (0.1 µM; 10 min) as described in Gray and Marshall (1992). Rings showing less than 70% relaxation of the maximal NE effect were discarded as having partially damaged endothelium. Supposedly endothelium-free rings showing relaxation by CB (1 µM; 10 min) after precontraction with NE (0.1 µM; 10 min) were excluded from further experiments.

Analysis of MLC20 Phosphorylation and Immunological Identification

The effects of Cant on MLC20 phosphorylation were determined in isolated rat aortic rings used in the contraction experiments. Rings were freeze-clamped at the end of contraction experiments (see Results) and stored at -80°C for approximately 1 week until biochemical studies. Analysis of MLC20 phosphorylation by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) was performed as described (Calovini et al., 1995; Knapp et al., 1999a; Waurick et al., 1999).

Isoelectric focusing (first dimension) was performed in glass capillaries (12.5 cm in length; 1 mm i.d.) with a pH gradient from 4.5 to 5.4 (pharmalytes; Pharmacia, Uppsala, Sweden). Gels were run for 4.5 h at 600 V constant for the first dimension. The second dimension was an SDS-electrophoresis with slab gels 10.5 × 9.5 cm, 1 mm in thickness. Gels were stained with Coomassie blue. MLC20 spots were scanned, quantitated by using ImageQuant software (Molecular Dynamics, Krefeld, Germany), and each MLC20 spot was expressed as percentage of whole MLC20 spots (=100%) detectable on one individual gel (Waurick et al., 1999).

The identification of the different MLC20 isoforms was based on their different isoelectric points. Because phosphorylation of MLC20 introduces negative charges, analysis by 2D-PAGE leads to different MLC20 isoforms having almost the same molecular mass but different isoelectric points where the most basic form (A) represents an unphosphorylated form (Haase and Morano, 1996). In addition, because the number and assumed phosphorylation state (un-, mono-, or biphosphorylated) of the other forms (B-F) varies in a species- and tissue-specific manner (Haase and Morano, 1996) and has not yet been identified in rat aorta, only relative changes of form A are reported in this study.

Separated proteins were transferred to nitrocellulose membranes and were incubated with monoclonal anti-myosin (light chains 20 kDa). Proteins binding the antibody were visualized with alkaline phosphatase-conjugated goat anti-mouse IgM and color reagents (Knapp et al., 1999a; Waurick et al., 1999). All MLC20 spots seen on Coomassie gels reacted with this anti-MLC20 antibody, whereas the essential light chains were not recognized by this antibody (data not shown).

Immunological Identification of PP1 and PP2A Catalytic Subunits

Rat aortic tissue (aorta thoracica descendens) was homogenized and separated proteins were transferred to nitrocellulose membranes as described recently (Knapp et al., 1998, 1999a,b). Antibodies against the catalytic subunits of PP1alpha and PP2A at 2-µg/ml dilution in Buffer A (13 mM Tris, 154 mM NaCl, pH 7.4, containing 5% nonfat dry milk powder) were incubated with the blot overnight. To demonstrate the specificity of bands, antibodies (2 µg/ml) were incubated with corresponding immunizing peptides for 8 h in Buffer A (PP1alpha , 6.6 µg/ml; PP2A, 16.6 µg/ml) and then incubated with the blot overnight. After several rinses in Tris-buffered saline/Tween 20, the nitrocellulose was incubated with 125I-goat anti-rabbit IgG (ICN Biomedicals, Eschwege, Germany), diluted 1:1000 in Tris-buffered saline for 4 h at room temperature. Radioactive bands were visualized in a PhosphorImager (Molecular Dynamics, Krefeld, Germany).

Phosphatase Activity

Preparation of Homogenates. Preparation of homogenates from rat aortae was performed according to the method described previously (Knapp et al., 1998). Aliquots of homogenates were used for determination of phosphatase activity.

Phosphatase Assay. Phosphatase activity was determined as described previously (Neumann et al., 1993; Knapp et al., 1998) with [32P]phosphorylase a as substrate. The reaction was started by adding aliquots of homogenates or aliquots of peak fractions. Reaction was stopped by addition of 50% trichloroacetic acid. Precipitated protein was sedimented by centrifugation and the supernatant was counted in a liquid scintillation counter.

Protein Determination

Protein was measured according to the method of Bradford (1976).

Chemicals

Benzamidine, NE, CB, leupeptin, phenylmethylsulfonyl fluoride, and Cant were from Sigma (Deisenhofen, Germany). CA and ETA were obtained from Calbiochem (Bad Soden, Germany) and Alexis (Grünberg, Germany), respectively. All chemicals used for high-resolution 2D-PAGE were from Pharmacia Biotech (Freiburg, Germany). Anti-human PP1 (rabbit polyclonal IgG, lot no. 12641), anti-human PP2A (rabbit polyclonal IgG, lot no. 13949), and corresponding immunizing peptides (human PP1 peptide, lot no. 12802; and PP2A peptide, lot no. 13298) were from BIOMOL (Hamburg, Germany). The antibody directed against the regulatory light chains of myosin (mouse monoclonal anti-myosin light chains 20 kDa; clone MY-21) was obtained from Sigma. All other chemicals used were of analytical or best grade commercially available.

Statistics

Results are expressed as mean ± S.E. Significance was estimated by Student's t test for paired and unpaired observations as appropriate. A P value less than .05 was considered significant

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

PP Activity in Homogenates of Rat Aorta. We measured phosphatase activity in the absence of Ca2+ with phosphorylase a as substrate (Fig. 1, control) where only PP1 and PP2A, but not PP2B and PP2C, are active (Cohen, 1989). These data suggest the presence of PP1 and/or PP2A.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   PP activity in homogenates of rat aorta. Effects of Cant (open circle ) and OA () on phosphatase activity (n = 3) in homogenates of rat aorta. Phosphatase activity is expressed as a percentage of solvent control (Ctr). The concentration of solvent (DMSO) was constant under all experimental conditions. Abscissa, concentrations of Cant or OA. Ordinate, phosphatase activity as a percentage of Ctr. star  denotes the first significant differences versus Ctr.

OA, a potent inhibitor of phosphatase activity in many tissues (Honkanen, 1993; Neumann et al., 1995; Herzig and Neumann, 2000) is structurally unrelated to Cant. OA attenuated phosphatase activity with an IC50 value of approximately 3 nM (n = 3) and completely blocked PP activity at 1 µM, a concentration that is specific for the inhibition of PP1 and PP2A.

Cant and CA reduced phosphatase activity in homogenates from rat aorta with IC50 values of approximately 300 nM. ETA was less potent with an IC50 value of 2 µM but was equieffective. Thus, Cant and CA are approximately 100-fold less potent but as effective as OA (Fig. 1).

Immunological Identification of PP1 and PP2A Catalytic Subunits. Next, we wanted to identify the catalytic subunits of PP1 and PP2A immunologically in rat aorta. Therefore, extracts from rat aorta were subjected to gel electrophoresis and transferred to nitrocellulose membranes. Several bands were visualized by the anti-phosphatase antibodies. The corresponding immunizing peptides only attenuated the prominent band at the expected molecular mass for PP1 or PP2A at approximately 37 kDa (Fig. 2). These data immunologically identify both PP1 and PP2A in the rat aorta.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Immunological identification of PP1 and PP2A. We homogenized isolated rat aortic rings as described in Materials and Methods and subjected them to electrophoresis. We transferred separated proteins to nitrocellulose membranes and incubated the membranes with polyclonal anti-phosphatase 1alpha (PP1), polyclonal anti-phosphatase 1alpha  + corresponding immunizing peptide (PP1 + IP), anti-phosphatase 2A (PP2A), and anti-phosphatase 2A + corresponding IP (PP2A + IP). Proteins binding antibodies were visualized with 125I-goat anti-rabbit IgG as described in Materials and Methods. Prominent bands at the expected molecular mass of approximately 37 kDa and molecular mass standards are indicated.

Effects of Cant on Force of Contraction in Isolated Endothelium-Intact Rat Aortic Rings. Isolated rings were equilibrated in bathing solution for 60 min and contracted with KCl (75 mM) twice as described in Materials and Methods. After washout, the presence of an undamaged endothelium was checked. Thereafter, one single concentration of Cant or solvent was added to each arterial ring.

Cant increased force of contraction in a concentration- and time-dependent manner with an EC50 value of 6.5 µM (Fig. 3). Cant (1 µM, n = 7 and 3 µM, n = 20) did not affect force of contraction within 180 min compared with control rings (n = 10). At higher concentrations (5, 7, and 10 µM) Cant led to a slowly developing and sustained increase in force of contraction. The most rapid increase in force of contraction could be observed at 30 and 100 µM Cant. The force generated by Cant (10 µM, 72.3 ± 3.0 mN; 30 µM, 68.7 ± 2.9 mN; and 100 µM, 70.2 ± 2.7 mN) was similar to the force generated by stimulation with 75 mM KCl (70.5 ± 1.0 mN). Thus, Cant is equieffective as KCl in contracting rat aortic rings. Additional experiments in endothelium-denuded preparations revealed that the effects of Cant did not depend on the presence of the endothelium (data not shown).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of Cant (1-100 µM) on force of contraction in endothelium-intact rat aortic rings. We exposed one single arterial ring to one single concentration of Cant or solvent. Values represent maximum force observed within 180 min (mean ± S.E.). Abscissa, concentration of Cant (µM). Ordinate, force of contraction (mN). We investigated at least five rings for each concentration of Cant. star  denotes significant differences versus control (Ctr; P < .05).

ETA (100 µM) and CA (100 µM), although inhibiting PP activity in broken cell preparations, did not affect force of contraction in isolated rat aortic rings. Maximum force within 180 min of exposure amounted to 14.3 ± 0.7 mN (100 µM CA, n = 7) and 15.3 mN ± 0.3 mN (100 µM ETA, n = 8).

As a next step we asked whether the different functional effects of PP inhibitors could be explained by different effects on the phosphorylation state of regulatory proteins in contracting rat aorta. To this end, MLC20 phosphorylation was determined in isolated rings that were rapidly frozen in liquid nitrogen at the end of the above-mentioned contraction experiments, i.e., after 180 min of exposure to Cant, CA, ETA, or solvent.

MLC20 Pattern. Under control conditions 2D-PAGE resolved four MLC20 forms (A-D with increasing acidity) in rat aortic rings (Fig. 4, left), whereas 2D-PAGE separated six MLC20 forms (A-F with increasing acidity) in rings frozen after treatment with 30 µM Cant for 180 min (Fig. 4, right).


View larger version (64K):
[in this window]
[in a new window]
 
Fig. 4.   MLC20 phosphorylation. Photographs of Coomassie blue-stained gels of endothelium-intact rat aortic rings treated with solvent for 180 min (Ctr, left) or 30 µM Cant for 180 min (right). MLC20 and MLC17 correspond to the 20-kDa (phosphorylatable) and 17-kDa (essential) MLC isoforms. A through F refer to 20-kDa light chain spots with increasing acidity.

The most basic MLC20 form, A, is a bona fide unphosphorylated form due to our experimental conditions and comprised 44.8 ± 2.7% (n = 7) of the total sum of MLC20 forms (=100%) in control rings. In isolated rat aortic rings exposed to 5 µM Cant for 180 min, also up to four MLC20 forms could be resolved. In these experiments, the relative amount of form A decreased to 18.8 ± 1.8% (n = 5).

By expressing the amount of the different isoforms as a percentage of all isoforms detectable (=100%) relative changes of form A are reported in this study. It is however, conceivable that an additional spot also represents another unphosphorylated MLC20 isoform. As in endothelial cells from human umbilical vein, form B may represent this additional unphosphorylated isoform (Goeckeler and Wysolmerski, 1995). If we summarize form A and form B as unphosphorylated isoforms, the amount of the phosphorylated forms would be approximately 20%. This would be in agreement with data from others where the amount of total phosphorylated MLC20 in rat aorta is approximately 10 to 15% (Jin et al., 1996; Takayama et al., 1996). Those studies used one-dimensional urea gel electrophoresis for the measurement of MLC20 phosphorylation. This experimental difference might explain the somewhat higher amount of unphosphorylated MLC20 (if summarizing form A and form B) in this study compared with the results of others.

In isolated rat aortic rings treated with 7, 10, and 30 µM Cant, 2D-PAGE revealed up to six MLC20 forms. In these experiments, the amount of the unphosphorylated form A decreased to 17.8 ± 2.0% (7 µM, n = 5), 12.9 ± 0.0% (10 µM), and 9.2 ± 1.5% (30 µM, n = 4).

Thus, Cant concentration dependently increased force of contraction and decreased the unphosphorylated MLC20 form A. Fittingly, CA and ETA failed to affect MLC20 phosphorylation in isolated contracting rat aorta (data not shown).

Effects of Cant on NE (0.1 µM)-Induced Contraction in Endothelium-Intact Preparations. First, cumulative concentration-response curves for NE (0.1 nM-100 µM) in endothelium-intact rat aorta were performed. In these experiments, 0.1 µM NE induced approximately half-maximal contraction of isolated aortic preparations similarly as described [Alosachie and Godfraind, 1988 (pD2 = 7.51); Xu et al., 1998 (pD2 = 7.09)]. Thus, we used this concentration (0.1 µM NE) to investigate the effects of Cant on NE-induced contraction in rat aorta.

Isolated rings were equilibrated in bathing solution for 60 min and contracted with KCl (75 mM) twice as described above. After washout, the presence of an undamaged endothelium was confirmed functionally by using CB.

In control rings (i.e., rings that were subsequently exposed to solvent) CB (1 µM) relaxed NE-precontracted rings by 80.5 ± 1.4% (n = 6). In rings that were subsequently treated with 1 or 3 µM Cant, CB relaxed preparations to a similar extent (1 µM, 77.2 ± 3.3%, n = 9; 3 µM, 78.0 ± 3.0%, n = 9; Fig. 5).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   Effects of Cant on NE (0.1 µM)-induced contraction in endothelium-intact rat aortic rings. We exposed rings to NE (0.1 µM) for 10 min and to CB (1 µM) for an additional 10 min in the presence of NE. After washout (WO) we incubated rings with 3 µM Cant (; n = 9), 1 µM Cant (; n = 9), or the solvent DMSO as control (Ctr; open circle ; n = 6) for 60 min. Then we contracted the rings again with 0.1 µM NE in the presence of Cant and solvent, respectively. Abcissa, time (min). Ordinate, force of contraction (mN). Time of application and time of exposure, respectively, of the indicated drugs are depicted in boxes. Symbols represent mean ± S.E.

In control rings, NE (0.1 µM) increased maximal force to 75.1 ± 4.8% (n = 6) of the maximal effect (=100%) during the first NE-induced contraction. In contrast, after exposure to 1 and 3 µM Cant, NE (0.1 µM) enhanced maximal force to 83.6 ± 2.4% (1 µM, n = 9) and 95.6 ± 4.4% (3 µM, n = 9) of the maximal effect (=100%) during the first NE-induced contraction (Fig. 5). Thus, treatment of endothelium-intact rings with Cant concentration dependently increased force of contraction induced by 0.1 µM NE.

Effects of Cant on NE (0.1 µM)-Induced Contraction in Endothelium-Denuded Preparations. To investigate whether the effects of Cant on NE-induced contraction depend on the presence of the endothelium, endothelium-denuded isolated rings were equilibrated in bathing solution for 60 min and contracted with KCl (75 mM) twice as described above. After washout, we confirmed the successful removal of the endothelium functionally. In control rings and rings that were subsequently treated with 3 µM Cant, respectively, CB (1 µM) did not relax rings after the first NE-induced contraction (n = 7 each; Fig. 6).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of Cant on NE (0.1 µM)-induced contraction in endothelium-denuded rat aortic rings. We exposed rings to NE (0.1 µM) for 10 min and to CB (1 µM) for additional 10 min in the presence of NE. After washout (WO) we incubated rings with 3 µM Cant (; n = 7) or the solvent DMSO as control (Ctr; open circle ; n = 7) for 60 min. Then we contracted rings again with 0.1 µM NE in the presence of Cant and solvent, respectively. Abcissa, time (min). Ordinate, force of contraction (mN). Time of application and time of exposure, respectively, of the indicated drugs are depicted in boxes. Symbols represent mean ± S.E.

In control rings, NE (0.1 µM) increased maximal force to 79.5 ± 3.9% (n = 7) of the maximal effect (=100%) during the first NE-induced contraction. In contrast to endothelium-intact rings, 3 µM Cant did not change NE-induced contraction (75.3 ± 3.1%, n = 7) compared with control rings (Fig. 6).

It is noteworthy that the second control contraction is weaker than the first contraction in endothelium-intact as well as in endothelium-denuded preparations. It is conceivable that the reduced second contraction observed herein is due to the solvent dimethyl sulfoxide (DMSO), which was absent in the first contraction. However, whenever we used Cant in our experiments a solvent control with the same constant concentration of DMSO in the organ bath was run. Hence, a head-to-head comparison is unequivocally possible.

Effects of Cant on NE (0.01-3 µM)-Induced Contraction in Endothelium-Intact Preparations. Treatment of endothelium-intact rings with Cant concentration dependently increased force of contraction induced by a single concentration (0.1 µM) of NE. However, if Cant can alter NE-induced contraction, a concentration-response curve for NE also would be predicted to be shifted leftward. Therefore, we performed concentration-response curves for NE in the absence and presence of Cant (1 and 3 µM). In these experiments, NE (0.01, 0.03, 0.1, 0.3, 1, and 3 µM) was cumulatively added for 10 min for each concentration. As expected, Cant produced a nonparallel shift to the left of the concentration-response curve to NE with an increase of the maximal response, indicating a functional noncompetitive antagonism (Fig. 7).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 7.   Effects of Cant on NE (0.01-3 µM)-induced contraction in endothelium-intact rat aortic rings. We exposed rings to NE (0.1 µM) for 10 min and to CB (1 µM) for additional 10 min in the presence of NE as described in Materials and Methods. After washout we incubated rings with 3 µM Cant (; n = 6), 1 µM Cant (; n = 4), or the solvent DMSO as control (Ctr; open circle ; n = 5) for 60 min (predrug value, PD). Then, NE (0.01, 0.03, 0.1, 0.3, 1, and 3 µM) was cumulatively added for 10 min, each concentration in the presence of Cant and solvent, respectively. Abcissa, time (min). Ordinate, force of contraction (mN). Symbols represent mean ± S.E.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The main new finding of this report is evidence for a possible link between PP inhibition and NE-induced vasoconstriction. This finding suggests that the endothelium mediates the interaction. We first discuss the characterization of PPs in the rat aorta, then their apparent interaction with NE-mediated vasoconstriction in this vessel, and finally, possible underlying mechanisms.

Identification of PP1 and PP2A in Rat Aorta. We have identified PP1 and PP2A by several criteria. Their enzymatic activity was measurable in the absence of Ca2+ with phosphorylase a as substrate, which is typical for these PPs (Cohen, 1989). The IC50 values for Cant and OA (Cohen et al., 1990; Honkanen, 1993) were comparable to that noted in homogenates of other tissues and species (Eldridge and Casida, 1995, Cant, IC50 = 250 nM [mouse femur muscle]; Gong et al., 1992, OA, IC50 values = 10 nM [guinea pig ileum] and 8 nM [rabbit femoral artery]). Finally, we could identify the catalytic subunits for PP1 and PP2A immunologically.

Based on work by others, we also tested additional PP inhibitors such as CA and ETA. These compounds inhibited phosphorylase a activity in broken cell preparations of rat aorta with a rank order of potency of Cant = CA > ETA. A similar rank order of potency of Cant and ETA has been reported (Erdödi et al., 1995, rabbit skeletal muscle). However, although CA and ETA were able to inhibit phosphatase activity in vitro, only Cant exerted functional effects in isolated rat aortic rings. The ineffectiveness of CA and ETA is probably due to impermeability through the cell membrane in smooth muscle. It could be argued that in contrast they might be membrane permeant but that their toxic effects limit their contractile functions. However, 75 mM KCl contracted rat aorta in the continuous presence of CA and ETA (data not shown). Hence, toxic effects are unlikely to play a major role. Others claimed that both Cant and ETA were not permeable across the plasmalemma (Erdödi et al., 1995, 1996) because they did not induce marked morphological changes in 3T3 fibroblasts. Although this impermeability may be the problem for ETA, this does not hold true for Cant in smooth muscle and cardiac preparations (Neumann et al., 1995; Linck et al., 1996; Knapp et al., 1999a,b; this article).

Biochemical experiments demonstrated the effectiveness of Cant in contracting tissue. It is important to note that these powerful experiments measured force and MLC20 phosphorylation in the very same tissue, which greatly facilitates their interpretation. Whereas CA and ETA did not affect force of contraction and the phosphorylation state of MLC20, Cant increased force and MLC20 phosphorylation in the same preparations and this was therefore in all likelihood mediated by PP inhibition. Based on these data we could use Cant as a tool to study the interaction of PPs and NE-induced contraction in smooth muscle.

Effects of Cant on NE-Induced Contraction. Stimulation of alpha -adrenoceptors in the smooth muscle may involve activation of MLC kinase but also G-protein-coupled inhibition of MLC20 phosphatase (Kitazawa et al., 1991; Shirazi et al., 1994; Somlyo and Somlyo, 1994).

Herein, subthreshold concentrations of Cant with respect to force of contraction (1 and 3 µM) increased NE-induced vasoconstriction in endothelium-intact rat aorta. These findings were obtained in experiments with a single concentration of NE (0.1 µM) as well as in experiments with cumulative application of NE (0.01-3 µM). An interpretation might be that inhibition of MLC20 phosphatase(s) in vascular smooth muscle enhances NE-induced contraction. If the effect of Cant observed in endothelium-intact preparations was due to inhibition of PP activity in smooth muscle cells, this effect should be endothelium independent. Surprisingly, Cant did not affect NE-induced contraction in endothelium-denuded rings. Thus, we must conclude that Cant modulates endothelium-dependent components of NE-induced contraction in rat aorta.

We noted significantly lower force generated by the first NE-induced contraction in endothelium-intact rings (Fig. 5) compared with endothelium-denuded preparations (Fig. 6). This depression of noradrenaline-induced contraction in endothelium-intact preparations has been reported in various arteries (Cocks and Angus, 1983, coronary arteries; Urabe et al., 1991, rat isolated mesenteric and femoral arteries). Especially, in isolated rat aorta, the removal of endothelium from rat aortic rings significantly increases maximal responses and decreases EC50 values for alpha -adrenoceptor agonists such as noradrenaline and phenylephrine (Alosachie and Godfraind, 1988). Thus, the reduced noradrenaline-induced contraction in the presence of endothelium depicted in Fig. 5 is in accordance with the observations of many other investigators.

Apparently, the NE-induced contraction in endothelium-intact rings is mediated by stimulation of alpha 1-adrenoceptors, whereas the subsequent relaxation is mediated by stimulation of endothelial alpha 2-adrenoceptors, resulting in higher [Ca2+]i and increased activation of endothelial nitric-oxide synthase (NOS). Thus, nitric oxide (NO) can attenuate alpha 1-adrenoceptor-mediated vasoconstriction (Bockman et al., 1996). Hence, it is tempting to speculate that endothelial NOS (eNOS) activity is reduced by Cant, most probably by phosphorylation (Sase and Michel, 1997).

Indeed, phosphorylation can reduce NOS activity. Phosphorylation of eNOS by AMP-activated protein kinase or protein kinase C inhibited NOS activity (Bredt et al., 1992; Chen et al., 1999). Other explanations also exist. Sutliff et al. (1999) demonstrated the expression of phospholamban (PLB) in the endothelium of mouse aorta. Unphosphorylated PLB inhibits Ca2+ uptake (Simmerman and Jones, 1998; Bokník et al., 1999) into the endoplasmic reticulum, resulting in higher [Ca2+]i and increased activation of eNOS (which is activated by Ca2+). Phosphorylation of PLB increases Ca2+ uptake into the endoplasmic reticulum. This lowers [Ca2+]i and should reduce NO production and thereby would attenuate any endothelium-dependent relaxation. Conceivably, Cant can increase the phosphorylation state of PLB in endothelial cells of rat aorta as described in cardiomyocytes (Neumann et al., 1995). Moreover, PP1 and PP2A are present in endothelial cells, are inhibited by in vitro Cant, and Cant enters endothelial cells because it increases the phosphorylation state of MLC20 in these cells (Knapp et al., 1999b).

It is possible or even likely that additional regulatory proteins besides eNOS and PLB are phosphorylated in endothelial cells in the presence of Cant and their phosphorylation may enhance the contraction by NE in rat aorta. Further work is required to elucidate the underlying mechanism(s). In summary, the data presented herein support a possible link between PP inhibition and NE-induced contraction that is mediated by the endothelium.

    Acknowledgments

The skillful technical assistance of Insa Post and Barbara Prystaj is gratefully acknowledged.

    Footnotes

Accepted for publication May 1, 2000.

Received for publication December 21, 1999.

1 This study was supported by the Deutsche Forschungsgemeinschaft and the Interdisziplinäres Zentrum für Klinische Forschung, Münster.

Send reprint requests to: Dr. med. Jörg Knapp, Institut für Pharmakologie und Toxikologie, Westfälische Wilhelms-Universität Münster, Domagkstraße 12, D-48129 Münster, FRG. E-mail: jknapp{at}uni-muenster.de

    Abbreviations

MLC20, regulatory light chains of myosin (20 kDa); PP, serine/threonine protein phosphatase; OA, okadaic acid; Cant, cantharidin; CA, cantharidic acid; ETA, endothall; NE, norepinephrine; KHS, Krebs-Henseleit solution; CB, carbachol; 2D-PAGE, two-dimensional polyacrylamide gel electrophoresis; DMSO, dimethyl sulfoxide; NOS, nitric-oxide synthase; NO, nitric oxide; eNOS, endothelial NOS; PLB, phospholamban; pD2, -log EC50.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0022-3565/00/2942-0620$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knapp, J.
Right arrow Articles by Neumann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knapp, J.
Right arrow Articles by Neumann, J.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition